Narcolepsy Drug Market 2020 Analysis and Precise Outlook - Jazz Pharmaceuticals, Teva Pharmaceutical

The report titled "Narcolepsy Drug Market" report will be very useful to get a stronger and effective business outlook. It provides an in-depth analysis of different attributes of industries such as trends, SWOT analysis, policies, and clients operating in several regions. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the readers, business owners and industry experts.

The global Narcolepsy Drug market is valued at 2255.9 million US$ in 2020 is expected to reach 4572.5 million US$ by the end of 2026, growing at a CAGR of 10.5% during 2021-2026.

Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time.

About 70% of people also experience episodes of sudden loss of muscle strength, known as cataplexy. These spells can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be worse.

Available discount (Exclusive Offer Flat 30%)

Click the link to get a Sample Copy of the Report before purchase:

https://www.marketinsightsreports.com/reports/01091739667/global-narcolepsy-drug-market-research-report-2020/inquiry?Source=Openpr&Mode=47

The report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market. Top Companies in the Global Narcolepsy Drug Market: Jazz Pharmaceuticals, Teva Pharmaceutical, Novartis, Mylan and others.

News Update:

May 14, 2020 (Jazz Pharmaceuticals)

"Jazz is committed to oncology, including developing meaningful hematologic and solid tumor therapies that address unmet needs of patients facing unique challenges and difficult odds," said Robert Iannone, M.D., M.S.C.E., executive vice president, research and development of Jazz Pharmaceuticals. "Our dedication to patient-centered research, through internal R&D capabilities and strategic external partnerships, will help ensure a greater number of people benefit from the development of new treatment options, as well as expand our presence in oncology."

MAY 18, 2020 (Teva Pharmaceutical)

TEL AVIV, Israel-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that the China National Medical Products Administration (NMPA) has approved AUSTEDO(Deutetrabenazine Tablets) for the treatment of chorea associated with Huntington's disease (HD) and Tardive Dyskinesia (TD) in adults, after a priority review. China is the second country in the world after the U.S. to have approved AUSTEDO.

Global Narcolepsy Drug Market Split By Product Type and Applications:

This report segments the global Narcolepsy Drug Market on the basis of Types are:
Antioxidants Type
Stimulants Type
Other

On the basis of Application, the Global Narcolepsy Drug Market is segmented into:
Daytime Extreme Sleepiness
Cataplexia
Others

Inquire for Discount:

https://www.marketinsightsreports.com/reports/01091739667/global-narcolepsy-drug-market-research-report-2020/discount?Source=Openpr&Mode=47

Regional Analysis For Narcolepsy Drug Market:

For the comprehensive understanding of market dynamics, the global Narcolepsy Drug Market is analysed across key geographies namely: United States, China, Europe, Japan, South-east Asia, India and others. Each of these regions is analysed on the basis of market findings across major countries in these regions for a macro-level understanding of the market.

Important Features that are under Offering and Key Highlights of the Reports:

- Detailed overview of Narcolepsy Drug Market.
- Changing market dynamics of the Narcolepsy Drug Market industry.
- In-depth segmentation of Narcolepsy Drug Market by Type, Application etc.
- Historical, current and projected market size in terms of volume and value.
- Recent industry trends and developments.
- Competitive landscape of Narcolepsy Drug Market.
- Strategies of key players and product offerings.
- Potential and niche segments/regions exhibiting promising growth.

Browse the report description and TOC:

https://www.marketinsightsreports.com/reports/01091739667/global-narcolepsy-drug-market-research-report-2020?Source=Openpr&Mode=47

We also offer customization on reports based on specific client requirement:

1- Country level analysis for any 5 countries of your choice.
2- Competitive analysis of any 5 key market players.
3- 40 analyst hours to cover any other data points

Reference and Source:

https://investor.jazzpharma.com/news-releases/news-release-details/jazz-pharmaceuticals-showcase-new-data-its-growing-oncology

https://www.tevapharm.com/news-and-media/latest-news/china-approves-austedo-for-treating-chorea-associated-with-huntingtons-disease-and-tardive-dyskinesia-i/

Market Insights Reports
4893, Pepper drive, Harrisburg ,NC 28075,United States

+Contact US :

Irfan Tamboli (Head of Sales)
Market Insights Reports
Phone: + 1704 266 3234 | Mob: +91-750-707-8687
sales@marketinsightsreports.com
irfan@marketinsightsreports.com

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare,
Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc.
MarketInsightsReports provides global and Chinese and regional market intelligence coverage,
a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.